<p>, /PRNewswire/ -- <strong>Ispire Technology Inc.</strong>（“Ispire” 或 “公司”）（NASDAQ: ISPR），一家在电子烟技术和精准剂量方面的创新者，以及 <strong>IKE Tech LLC</strong>（“IKE Tech”），一个包括 Ispire 作为创始合作伙伴的合资企业，在美国食品和药物管理局（FDA）获得国会资金并指示打击非法电子烟市场后发布了声明。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.jpg"/></p>
<p>作为国会通过并由特朗普总统签署的持续决议的一部分，FDA 现在必须将其 7.12 亿美元用户费用中的至少 2 亿美元用于加强对电子尼古丁传递系统（ENDS）的监管。这包括 200 万美元用于支持一个多机构工作组——涉及司法部和国土安全部——专注于清除从国外进入美国的非法 ENDS 产品。FDA 还必须更新其 2020 年的执法指导，以解决调味一次性电子烟的问题，并每年向国会报告两次其进展。</p>
<p><strong>IKE Tech 的总裁约翰·帕特森（John Patterson）表示：</strong></p>
<p><em>今天的执法行动是对一个失去自身标准的行业的警醒。当货架上十个电子烟中有九个是非法的时，显然反应性的边境管控和纸质追踪机制并不起作用。我们赞扬美国国会和 FDA 采取果断行动，清理一个充斥着未监管产品的市场，这些产品使用户——尤其是青少年——面临潜在危害。</em></p>
<p><em>IKE Tech 和我们的合资伙伴正在为这些努力构建技术基础；从区块链安全的智能认证标签，使每个供应链环节的产品追踪实时化，到 AI 驱动的可互操作年龄验证解决方案，确保只有经过验证的成年人才能激活设备。这些工具可以帮助边境执法人员、监管机构和制造商即时验证产品的合法性，加强合规性，打击假冒产品，并防止非法进口进入美国市场。</em></p>
<p><em>这就是能够最终使监管者、制造商和消费者围绕公共安全和青少年预防的共同目标达成一致的内置安全。</em></p>
<p><strong>Ispire Technology 的联合首席执行官迈克尔·王（Michael Wang）补充道：</strong></p>
<p><em>FDA 的重新打击是正确的举措，但反应性执法必须与主动的技术标准相结合。非法进口不仅侵蚀了 FDA 的权威，还扭曲了执法，压垮了合法供应链，使负责任和合规的公司难以竞争。要赢得这场斗争，我们必须投资于能够在市场上提供双重安全的技术，包括在使用点验证产品合法性的新工具。</em></p>
<p><em>Ispire 和 IKE Tech 的区块链驱动、已提交给 FDA 的年龄验证芯片在设备级别提供实时身份验证，确保只有经过验证的成年人才能激活电子烟，而不仅仅是购买。通过将执法与创新结合，我们可以重建信任，保护青少年，并将 300 亿美元的调味电子烟市场重新纳入合法、负责任的控制之下。</em></p>
<p>Ispire 和 IKE Tech 都强调，FDA 加强的执法授权代表了一个重要的第一步，但必须与主动的、基于技术的解决方案相结合，以防止非法产品在市场上泛滥，同时在产品到达消费者之前确保设备不被滥用。他们共同开发的区块链启用的系统芯片，作为今年早些时候提交给 FDA 的预市场烟草产品申请（PMTA）的一部分，为行业提供了可验证、可互操作的合规路径。</p>
<p><strong>关于 IKE Tech LLC</strong> IKE Tech LLC（“IKE Tech”）正在开创实时身份验证和产品认证，帮助保护对年龄限制产品的访问。</p>
<p>成立于 2024 年，IKE Tech 正在为物理世界构建身份层。凭借涵盖区块链认证、安全 BLE 通信和 AI 增强访问控制的专利技术，IKE Tech 为受监管和高风险领域的安全、以用户为中心的设备交互提供动力。</p>
<p>IKE Tech 的可互操作蓝牙低能耗（BLE）系统芯片，配备用户友好的移动应用程序，适用于 iOS 和 Android，能够无缝集成到 ENDS 设备中，为制造商和监管机构提供灵活、未来可持续的解决方案，以打击未成年人吸烟和非法市场。通过设定负责任的仅限成年人访问的新标准，IKE Tech 正在帮助彻底消除青少年吸烟。</p>
<p><strong>关于 Ispire Technology Inc.</strong> Ispire 从事品牌电子烟和大麻电子烟产品的研究与开发、设计、商业化、销售、市场营销和分销。公司的运营子公司在全球拥有或许可超过 400 项专利。Ispire 的品牌电子烟产品以 Aspire 名称进行市场营销，并通过其全球分销网络在全球销售（不包括美国、中国和俄罗斯）。公司还与全球电子烟品牌和零售商建立了原始设计制造（ODM）关系。公司的大麻产品主要以 Ispire 品牌名称在 ODM 基础上销售给其他大麻蒸汽公司。Ispire 在美国、欧洲和南非销售其大麻电子烟硬件，并最近开始在加拿大和拉丁美洲进行市场营销活动和客户互动。有关更多信息，请访问 www.ispiretechnology.com 或在 Instagram、LinkedIn、X 和 YouTube 上关注 Ispire。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含根据《1933 年证券法》第 27A 条（经修订）和《1934 年证券交易法》第 21E 条（经修订）以及《1995 年私人证券诉讼改革法案》（经修订）所定义的前瞻性声明，这些声明旨在受到这些条款所创建的安全港的保护。前瞻性声明基于某些假设，描述了公司的未来计划、战略和预期，通常可以通过使用诸如 “相信”、“期望”、“可能”、“将”、“应该”、“会”、“能够”、“寻求”、“打算”、“计划”、“目标”、“项目”、“估计”、“预期”、“战略”、“未来”、“可能” 等前瞻性术语来识别，尽管并非所有前瞻性声明都包含这些识别词。除历史事实声明外，本新闻稿中关于公司战略、前景、财务状况、运营、成本、计划和目标的所有声明均为前瞻性声明。可能导致公司实际结果和财务状况与前瞻性声明中所指示的结果存在重大差异的重要因素。这些前瞻性声明包括但不限于风险和不确定性，包括：公司是否能够成功重新进入美国电子烟市场；公司提交的任何 PMTA 的批准或拒绝；公司是否能够成功进一步扩展到非洲市场；公司与 Touch Point Worldwide Inc.（以 Berify 和 Chemular Inc.名义运营）的合资企业（“合资企业”）是否能够成功实现其当前设想的目标，或以不同条款实现目标，或根本无法实现；合资企业在电子烟技术领域创新的能力或为尼古丁蒸汽设备开发年龄限制或年龄验证技术的能力；公司及时收回应收账款的能力；公司的商业战略；公司向 Ispire ONE™的市场营销能力；Ispire ONE™在实现其目标方面的成功；客户从 Ispire ONE™中获得预期收益的能力以及其产品在市场上的成功；Ispire ONE™被证明是安全的；以及在 Ispire 截至 2025 年 6 月 30 日的年度报告的 “风险因素”、“管理层对财务状况和经营成果的讨论与分析”、“前瞻性声明的警示说明” 以及 Ispire 向 SEC 提交的任何后续文件中描述的风险和不确定性。您不应将前瞻性声明视为对未来事件的预测。本新闻稿中所作的前瞻性声明仅与声明发布之日的事件或信息相关。我们没有义务更新或修订任何前瞻性声明，无论是由于新信息、未来事件还是其他原因，声明发布之日后，或反映意外事件的发生，除非适用法律要求。您应理解，本新闻稿的实际未来结果可能与我们预期的结果存在重大差异。</p>
<p><strong>投资者关系联系人：</strong></p>
<p>KCSA 战略传播</p>
<p>Phil Carlson</p>
<p>212.896.1233</p>
<p>ispire@kcsa.com</p>
<p><strong>公关联系人：</strong></p>
<p>Ellen Mellody</p>
<p>570.209.2947</p>
<p>EMellody@kcsa.com</p>
<p>来源：Ispire Technology Inc.</p>

ISPR

<p>Ispire Technology 和 IKE Tech 对 FDA 对非法电子烟市场的打击表示赞赏，强调需要技术驱动的执法来保护青少年。FDA 被要求拨款 2 亿美元用于监管电子尼古丁传递系统，包括成立一个专门小组来打击非法进口。Ispire 和 IKE Tech 倡导使用区块链和人工智能解决方案，以确保产品的合法性和年龄验证，旨在使监管机构、制造商和消费者在公共安全方面达成一致</p>

<p>, /PRNewswire/ -- <strong>Ispire Technology Inc.</strong>(&#34;Ispire&#34; or the &#34;Company&#34;) (NASDAQ: ISPR), an innovator in vaping technology and precision dosing, and <strong>IKE Tech LLC</strong>(&#34;IKE Tech&#34;), a joint venture that includes Ispire as a founding partner, released statements following the U.S. Food and Drug Administration's (FDA) Congressional funding and directive to combat the illicit vape market.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- <strong>Ispire Technology Inc.</strong>（“Ispire” 或 “公司”）（NASDAQ: ISPR），一家在电子烟技术和精准剂量方面的创新者，以及 <strong>IKE Tech LLC</strong>（“IKE Tech”），一个包括 Ispire 作为创始合作伙伴的合资企业，在美国食品和药物管理局（FDA）获得国会资金并指示打击非法电子烟市场后发布了声明。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.jpg" alt="" original-src="https://mma.prnewswire.com/media/2771569/Ispire_Technology_Logo.jpg"/></p>
<p>As part of the continuing resolution passed by Congress and signed by President Trump, the FDA is now required to allocate at least $200 million of its $712 million in user fees toward enforcing regulations on electronic nicotine delivery systems (ENDS). This includes $2 million to support a multi-agency task force — involving the Departments of Justice and Homeland Security — focused on removing illegal ENDS products entering the U.S. from abroad. The FDA must also update its 2020 enforcement guidance to address flavored disposable vapes and report to Congress twice yearly on its progress.</p>
<div class="lb-trans"><p>作为国会通过并由特朗普总统签署的持续决议的一部分，FDA 现在必须将其 7.12 亿美元用户费用中的至少 2 亿美元用于加强对电子尼古丁传递系统（ENDS）的监管。这包括 200 万美元用于支持一个多机构工作组——涉及司法部和国土安全部——专注于清除从国外进入美国的非法 ENDS 产品。FDA 还必须更新其 2020 年的执法指导，以解决调味一次性电子烟的问题，并每年向国会报告两次其进展。</p>
</div><p><strong>John Patterson, president of IKE Tech, said:</strong></p>
<div class="lb-trans"><p><strong>IKE Tech 的总裁约翰·帕特森（John Patterson）表示：</strong></p>
</div><p><em>Today's enforcement push is a wake-up call for an industry that's lost control of its own standards. When nine out of ten vapes on shelves are illegal, it's clear that reactive border controls and paper-based tracking mechanisms aren't working. We commend the U.S. Congress and FDA for taking decisive action to clean up a market that's been flooded with unregulated products that are exposing users – especially youth – to potential harms.</em></p>
<div class="lb-trans"><p><em>今天的执法行动是对一个失去自身标准的行业的警醒。当货架上十个电子烟中有九个是非法的时，显然反应性的边境管控和纸质追踪机制并不起作用。我们赞扬美国国会和 FDA 采取果断行动，清理一个充斥着未监管产品的市场，这些产品使用户——尤其是青少年——面临潜在危害。</em></p>
</div><p><em>IKE Tech and our JV partners are building the technological backbone for these efforts; from blockchain-secured smart authentication tags that enable real-time product tracing at every step of the supply chain, to AI-driven interoperable age-verification solutions that ensure only verified adults can activate a device. Together, these tools can help border agents, regulators and manufacturers verify product legitimacy instantly, reinforcing compliance, combating counterfeits and keeping illegal imports out of U.S. markets.</em></p>
<div class="lb-trans"><p><em>IKE Tech 和我们的合资伙伴正在为这些努力构建技术基础；从区块链安全的智能认证标签，使每个供应链环节的产品追踪实时化，到 AI 驱动的可互操作年龄验证解决方案，确保只有经过验证的成年人才能激活设备。这些工具可以帮助边境执法人员、监管机构和制造商即时验证产品的合法性，加强合规性，打击假冒产品，并防止非法进口进入美国市场。</em></p>
</div><p><em>This is the kind of built-in security that can finally align regulators, manufacturers and consumers around the shared goal of public safety and youth prevention.</em></p>
<div class="lb-trans"><p><em>这就是能够最终使监管者、制造商和消费者围绕公共安全和青少年预防的共同目标达成一致的内置安全。</em></p>
</div><p><strong>Michael Wang, co-CEO of Ispire Technology, added:</strong></p>
<div class="lb-trans"><p><strong>Ispire Technology 的联合首席执行官迈克尔·王（Michael Wang）补充道：</strong></p>
</div><p><em>The FDA's renewed crackdown is the right move, but reactive enforcement must be paired with proactive technological standards. Illicit imports don't only erode FDA authority, they distort enforcement, overwhelm legitimate supply chains and make it challenging for responsible and compliant companies to compete. To win the fight, we must invest in technology that delivers dual security across the market, including new tools to verify product legitimacy at the point of use.</em></p>
<div class="lb-trans"><p><em>FDA 的重新打击是正确的举措，但反应性执法必须与主动的技术标准相结合。非法进口不仅侵蚀了 FDA 的权威，还扭曲了执法，压垮了合法供应链，使负责任和合规的公司难以竞争。要赢得这场斗争，我们必须投资于能够在市场上提供双重安全的技术，包括在使用点验证产品合法性的新工具。</em></p>
</div><p><em>Ispire and IKE Tech's blockchain-powered, FDA-submitted age-verification chip delivers real-time identity validation at the device level, ensuring only verified adults can activate a vape, not just purchase one. By pairing enforcement with innovation, we can rebuild trust, protect youth and bring the $30 billion flavored vape market back under lawful, responsible control.</em></p>
<div class="lb-trans"><p><em>Ispire 和 IKE Tech 的区块链驱动、已提交给 FDA 的年龄验证芯片在设备级别提供实时身份验证，确保只有经过验证的成年人才能激活电子烟，而不仅仅是购买。通过将执法与创新结合，我们可以重建信任，保护青少年，并将 300 亿美元的调味电子烟市场重新纳入合法、负责任的控制之下。</em></p>
</div><p>Both Ispire and IKE Tech emphasized that the FDA's strengthened enforcement mandate represents a vital first step, but one that must be paired with proactive, technology-based solutions that prevent illicit products proliferating the market, while securing devices from misuse before they reach consumers. Their jointly developed blockchain-enabled System-on-a-Chip, submitted to the FDA earlier this year as part of a Pre-Market Tobacco Product Application (PMTA), offers a path toward verifiable, interoperable compliance across the industry.</p>
<div class="lb-trans"><p>Ispire 和 IKE Tech 都强调，FDA 加强的执法授权代表了一个重要的第一步，但必须与主动的、基于技术的解决方案相结合，以防止非法产品在市场上泛滥，同时在产品到达消费者之前确保设备不被滥用。他们共同开发的区块链启用的系统芯片，作为今年早些时候提交给 FDA 的预市场烟草产品申请（PMTA）的一部分，为行业提供了可验证、可互操作的合规路径。</p>
</div><p><strong>About IKE Tech LLC</strong> IKE Tech LLC (&#34;IKE Tech&#34;) is pioneering real-time identity verification and product authentication, helping to safeguard access to age-restricted products.</p>
<div class="lb-trans"><p><strong>关于 IKE Tech LLC</strong> IKE Tech LLC（“IKE Tech”）正在开创实时身份验证和产品认证，帮助保护对年龄限制产品的访问。</p>
</div><p>Founded in 2024, IKE Tech is building the identity layer for the physical world. With patented technologies spanning blockchain authentication, secure BLE communication, and AI-enhanced access control, IKE Tech powers secure, user-centric device interactions across regulated and high-risk sectors.</p>
<div class="lb-trans"><p>成立于 2024 年，IKE Tech 正在为物理世界构建身份层。凭借涵盖区块链认证、安全 BLE 通信和 AI 增强访问控制的专利技术，IKE Tech 为受监管和高风险领域的安全、以用户为中心的设备交互提供动力。</p>
</div><p>IKE Tech's interoperable Bluetooth Low Energy (BLE) System-on-a-Chip, powered by a user-friendly mobile app available on iOS and Android, integrates seamlessly into ENDS devices, giving manufacturers and regulators a flexible, future-proofed solution to combat underage vaping and illicit markets. By setting the new standard for responsible, adult-only access, IKE Tech is helping eliminate youth vaping for good.</p>
<div class="lb-trans"><p>IKE Tech 的可互操作蓝牙低能耗（BLE）系统芯片，配备用户友好的移动应用程序，适用于 iOS 和 Android，能够无缝集成到 ENDS 设备中，为制造商和监管机构提供灵活、未来可持续的解决方案，以打击未成年人吸烟和非法市场。通过设定负责任的仅限成年人访问的新标准，IKE Tech 正在帮助彻底消除青少年吸烟。</p>
</div><p><strong>About Ispire Technology Inc.</strong> Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People's Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company's cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visitwww.ispiretechnology.comor follow Ispire onInstagram, LinkedIn, Xand YouTube.</p>
<div class="lb-trans"><p><strong>关于 Ispire Technology Inc.</strong> Ispire 从事品牌电子烟和大麻电子烟产品的研究与开发、设计、商业化、销售、市场营销和分销。公司的运营子公司在全球拥有或许可超过 400 项专利。Ispire 的品牌电子烟产品以 Aspire 名称进行市场营销，并通过其全球分销网络在全球销售（不包括美国、中国和俄罗斯）。公司还与全球电子烟品牌和零售商建立了原始设计制造（ODM）关系。公司的大麻产品主要以 Ispire 品牌名称在 ODM 基础上销售给其他大麻蒸汽公司。Ispire 在美国、欧洲和南非销售其大麻电子烟硬件，并最近开始在加拿大和拉丁美洲进行市场营销活动和客户互动。有关更多信息，请访问 www.ispiretechnology.com 或在 Instagram、LinkedIn、X 和 YouTube 上关注 Ispire。</p>
</div><p><strong>Forward Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (&#34;Securities Act&#34;) as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as &#34;believe,&#34; &#34;expect,&#34; &#34;may,&#34; &#34;will,&#34; &#34;should,&#34; &#34;would,&#34; &#34;could,&#34; &#34;seek,&#34; &#34;intend,&#34; &#34;plan,&#34; &#34;goal,&#34; &#34;project,&#34; &#34;estimate,&#34; &#34;anticipate,&#34; &#34;strategy,&#34; &#34;future,&#34; &#34;likely&#34; or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: whether the Company may be successful in re-entering the U.S. ENDS market; the approval or rejection of any PMTA submitted by the Company; whether the Company will be successful in its plans to further expand into the African market; whether the Company's joint venture with Touch Point Worldwide Inc. d/b/a/ Berify and Chemular Inc. (the &#34;Joint Venture&#34;) may be successful in achieving its goals as currently contemplated, with different terms, or at all; the Joint Venture's ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices; the Company's ability to collect its accounts receivable in a timely manner; the Company's business strategies; the ability of the Company to market to the Ispire ONE™; Ispire ONE™'s success in meeting its goals; the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of its products on the markets; the Ispire ONE™ proving to be safe; and the risk and uncertainties described in &#34;Risk Factors,&#34; &#34;Management's Discussion and Analysis of Financial Condition and Results of Operations,&#34; &#34;Cautionary Note on Forward-Looking Statements&#34; and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2025 and any subsequent filings which Ispire makes with the SEC. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by applicable law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.</p>
<div class="lb-trans"><p>本新闻稿包含根据《1933 年证券法》第 27A 条（经修订）和《1934 年证券交易法》第 21E 条（经修订）以及《1995 年私人证券诉讼改革法案》（经修订）所定义的前瞻性声明，这些声明旨在受到这些条款所创建的安全港的保护。前瞻性声明基于某些假设，描述了公司的未来计划、战略和预期，通常可以通过使用诸如 “相信”、“期望”、“可能”、“将”、“应该”、“会”、“能够”、“寻求”、“打算”、“计划”、“目标”、“项目”、“估计”、“预期”、“战略”、“未来”、“可能” 等前瞻性术语来识别，尽管并非所有前瞻性声明都包含这些识别词。除历史事实声明外，本新闻稿中关于公司战略、前景、财务状况、运营、成本、计划和目标的所有声明均为前瞻性声明。可能导致公司实际结果和财务状况与前瞻性声明中所指示的结果存在重大差异的重要因素。这些前瞻性声明包括但不限于风险和不确定性，包括：公司是否能够成功重新进入美国电子烟市场；公司提交的任何 PMTA 的批准或拒绝；公司是否能够成功进一步扩展到非洲市场；公司与 Touch Point Worldwide Inc.（以 Berify 和 Chemular Inc.名义运营）的合资企业（“合资企业”）是否能够成功实现其当前设想的目标，或以不同条款实现目标，或根本无法实现；合资企业在电子烟技术领域创新的能力或为尼古丁蒸汽设备开发年龄限制或年龄验证技术的能力；公司及时收回应收账款的能力；公司的商业战略；公司向 Ispire ONE™的市场营销能力；Ispire ONE™在实现其目标方面的成功；客户从 Ispire ONE™中获得预期收益的能力以及其产品在市场上的成功；Ispire ONE™被证明是安全的；以及在 Ispire 截至 2025 年 6 月 30 日的年度报告的 “风险因素”、“管理层对财务状况和经营成果的讨论与分析”、“前瞻性声明的警示说明” 以及 Ispire 向 SEC 提交的任何后续文件中描述的风险和不确定性。您不应将前瞻性声明视为对未来事件的预测。本新闻稿中所作的前瞻性声明仅与声明发布之日的事件或信息相关。我们没有义务更新或修订任何前瞻性声明，无论是由于新信息、未来事件还是其他原因，声明发布之日后，或反映意外事件的发生，除非适用法律要求。您应理解，本新闻稿的实际未来结果可能与我们预期的结果存在重大差异。</p>
</div><p><strong>IR Contacts:</strong></p>
<div class="lb-trans"><p><strong>投资者关系联系人：</strong></p>
</div><p>KCSA Strategic Communications</p>
<div class="lb-trans"><p>KCSA 战略传播</p>
</div><p>Phil Carlson</p>
<div class="lb-trans"><p>Phil Carlson</p>
</div><p>212.896.1233</p>
<div class="lb-trans"><p>212.896.1233</p>
</div><p>ispire@kcsa.com</p>
<div class="lb-trans"><p>ispire@kcsa.com</p>
</div><p><strong>PR Contact:</strong></p>
<div class="lb-trans"><p><strong>公关联系人：</strong></p>
</div><p>Ellen Mellody</p>
<div class="lb-trans"><p>Ellen Mellody</p>
</div><p>570.209.2947</p>
<div class="lb-trans"><p>570.209.2947</p>
</div><p>EMellody@kcsa.com</p>
<div class="lb-trans"><p>EMellody@kcsa.com</p>
</div><p>SOURCE Ispire Technology Inc.</p>
<div class="lb-trans"><p>来源：Ispire Technology Inc.</p>
</div>

Ispire Technology 和 IKE Tech 对 FDA 的打击行动表示赞赏，并呼吁通过技术驱动的执法来防止非法贸易和保护青少年 | ISPR 股票新闻